Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Peter H. Goff, Louis B. Harrison, Eli Furhang, Evan Ng, Stephen Bhatia, Frieda Trichter, Ronald D. Ennis
Abstract
Rights: UNKNOWN · cc-by-nc-nd · Source: journal-auto-sync:external:CROSSREF_ISSN
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Unresolved referenced work
Kept as external metadata until matched
Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: Toxicity and biochemical outcomes
10.1016/j.ijrobp.2007.10.004 · 2008
Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer
10.1016/j.ijrobp.2007.11.044 · 2008
Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial
10.1016/j.ijrobp.2013.07.041 · 2013
Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer
10.1016/j.ijrobp.2012.05.023 · 2013
Outcomes after intensity-modulated versus conformal radiotherapy in older men with nonmetastatic prostate cancer
10.1016/j.ijrobp.2011.02.006 · 2011
Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer
10.1016/j.ijrobp.2007.06.054 · 2008
Clinical impact of margin reduction on late toxicity and short-term biochemical control for patients treated with daily on-line image guided IMRT for prostate cancer
10.1016/j.radonc.2011.10.025 · 2012
Image-guided radiotherapy of the prostate using daily CBCT: The feasibility and likely benefit of implementing a margin reduction
10.1259/bjr.20140459 · 2014
Acute toxicity after image-guided intensity modulated radiation therapy compared to 3D conformal radiation therapy in prostate cancer patients
10.1016/j.ijrobp.2014.12.017 · 2015
Late side effects after image guided intensity modulated radiation therapy compared to 3D-conformal radiation therapy for prostate cancer: Results from 2 prospective cohorts
10.1016/j.ijrobp.2016.01.031 · 2016
The effectiveness of intensity modulated radiation therapy versus three-dimensional radiation therapy in prostate cancer: A meta-analysis of the literatures
10.1371/journal.pone.0154499 · 2016
Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer
10.1016/j.ijrobp.2011.11.047 · 2012
Radiation dose escalation for localized prostate cancer: intensity-modulated radiotherapy versus permanent transperineal brachytherapy
10.1002/cncr.24558 · 2009
Time trends in organ position and volume in patients receiving prostate three-dimensional conformal radiotherapy
10.1016/s0167-8140(01)00466-2 · 2002
Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging
10.1016/j.ijrobp.2005.02.022 · 2005
Feasibility of insertion/implantation of 2.0-mm-diameter gold internal fiducial markers for precise setup and real-time tumor tracking in radiotherapy
10.1016/s0360-3016(03)00076-2 · 2003
Image-guided radiotherapy (IGRT) for prostate cancer comparing kV imaging of fiducial markers with cone beam computed tomography (CBCT)
10.1016/j.ijrobp.2010.06.007 · 2011
Comparison of localization performance with implanted fiducial markers and cone-beam computed tomography for on-line image-guided radiotherapy of the prostate
10.1016/j.ijrobp.2006.10.039 · 2007
Comparison of CT on rails with electronic portal imaging for positioning of prostate cancer patients with implanted fiducial markers
10.1016/j.ijrobp.2009.01.054 · 2009
MRI-guided prostate adaptive radiotherapy - A systematic review
10.1016/j.radonc.2016.04.014 · 2016
A review of prostate motion with considerations for the treatment of prostate cancer
10.1016/j.meddos.2005.03.005 · 2005
Daily patient setup error in prostate image guided radiation therapy with fiducial-based kilovoltage onboard imaging and conebeam computed tomography
2015
Comparison of the accuracy and precision of prostate localization with 2D-2D and 3D images
10.1016/j.radonc.2010.11.012 · 2011
Evaluation of inter-fraction prostate motion using kilovoltage cone beam computed tomography during radiotherapy
10.1016/j.clon.2011.03.007 · 2011
Assessment of cone beam CT registration for prostate radiation therapy: Fiducial marker and soft tissue methods
10.1111/1754-9485.12197 · 2015
Magnitude of observer error using cone beam CT for prostate interfraction motion estimation: Effect of reducing scan length or increasing exposure
10.1259/bjr.20150208 · 2015
Analysis of interfraction prostate motion using megavoltage cone beam computed tomography
10.1016/j.ijrobp.2008.07.002 · 2008
Technique for implantation of fiducial markers in the prostate
10.1016/j.urology.2007.10.011 · 2008
Errors and margins in radiotherapy
10.1053/j.semradonc.2003.10.003 · 2004
The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy
10.1016/s0360-3016(00)00518-6 · 2000
No additional external references are available.